NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Belgium's Solvay to buy U.S. peer Cytec for $5.5 billion

Published 29/07/2015, 06:51
© Reuters. The statue of Ernest Solvay is seen outside the company's headquarters in Brussels
SOLB
-
CYT
-

BRUSSELS (Reuters) - Belgian chemical group Solvay (BR:SOLB) will buy U.S. peer Cytec (N:CYT) for $5.5 billion (3.5 billion pounds) to boost its presence in lightweight composites for planes and cars and reinforce its mining chemicals business.

Cytec, which makes most of its sales in North America, has 4,600 employees worldwide and annual sales of about $2.0 billion.

It makes composite and adhesive materials for the aerospace and automotive industries and reagent chemicals used in the mining sector for mineral processing and solvent extraction.

Solvay said in a statement on Wednesday it would pay $75.25 per share for Cytec in cash, which closed at $58.39 on Tuesday.

The Belgian company said the enterprise value, which includes debt, was $6.4 billion, representing a 2015 estimated

core profit (EBITDA) multiple of 14.7 times and of 11.7 times when considering potential synergies.

Solvay expects to make annual savings of 100 million euros within three years of the merger and added that Cytec would add to its earnings per share after the first year.

The Belgian group will finance the transaction with a 1.5 billion euros (1.06 billion pounds) rights issue, 1.0 billion euros of hybrid debt instruments and a senior debt issue.

Solvay also announced its second quarter results on Wednesday. Core profit, adjusted for one-off items rose 8.1 percent in the second quarter to 500 million euros, in line with the 499 million expected in a Reuters poll of seven analysts.

© Reuters. The statue of Ernest Solvay is seen outside the company's headquarters in Brussels

The company said its speciality materials and chemicals businesses gained, but demand declined substantially for chemicals used in the oil and gas sector.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.